 | • レポートコード：MRC2-11QY00895 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は椎間板変性症治療薬のグローバル市場について調査・分析したレポートです。種類別（ALLOB、AMG-0101、BRTX-100、OTICR-01、その他）市場規模、用途別（クリニック、病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別椎間板変性症治療薬の競争状況、市場シェア ・世界の椎間板変性症治療薬市場：種類別市場規模 2015年-2020年（ALLOB、AMG-0101、BRTX-100、OTICR-01、その他） ・世界の椎間板変性症治療薬市場：種類別市場規模予測 2021年-2026年（ALLOB、AMG-0101、BRTX-100、OTICR-01、その他） ・世界の椎間板変性症治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、在宅医療） ・世界の椎間板変性症治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、在宅医療） ・北米の椎間板変性症治療薬市場分析：米国、カナダ ・ヨーロッパの椎間板変性症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの椎間板変性症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の椎間板変性症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの椎間板変性症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AnGes MG Inc、Biopharm GmbH、BioRestorative Therapies Inc、Bone Therapeutics SA、DiscGenics Inc、Osiris Therapeutics Inc、Samumed LLC、TissueGene Inc、U.S. Stem Cell Inc、Yuhan Corp ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Degenerative Disc Disease Threpeutics Market
The global Degenerative Disc Disease Threpeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Degenerative Disc Disease Threpeutics Scope and Market Size
Degenerative Disc Disease Threpeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Degenerative Disc Disease Threpeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Degenerative Disc Disease Threpeutics market is segmented into
ALLOB
AMG-0101
BRTX-100
OTICR-01
Others
Segment by Application, the Degenerative Disc Disease Threpeutics market is segmented into
Clinic
Hospital
Homecare
Regional and Country-level Analysis
The Degenerative Disc Disease Threpeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Degenerative Disc Disease Threpeutics market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Degenerative Disc Disease Threpeutics Market Share Analysis
Degenerative Disc Disease Threpeutics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Degenerative Disc Disease Threpeutics business, the date to enter into the Degenerative Disc Disease Threpeutics market, Degenerative Disc Disease Threpeutics product introduction, recent developments, etc.
The major vendors covered:
AnGes MG Inc
Biopharm GmbH
BioRestorative Therapies Inc
Bone Therapeutics SA
DiscGenics Inc
Osiris Therapeutics Inc
Samumed LLC
TissueGene Inc
U.S. Stem Cell Inc
Yuhan Corp
1 Study Coverage
1.1 Degenerative Disc Disease Threpeutics Product Introduction
1.2 Market Segments
1.3 Key Degenerative Disc Disease Threpeutics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Type
1.4.2 ALLOB
1.4.3 AMG-0101
1.4.4 BRTX-100
1.4.5 OTICR-01
1.4.6 Others
1.5 Market by Application
1.5.1 Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Homecare
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Degenerative Disc Disease Threpeutics Market Size, Estimates and Forecasts
2.1.1 Global Degenerative Disc Disease Threpeutics Revenue 2015-2026
2.1.2 Global Degenerative Disc Disease Threpeutics Sales 2015-2026
2.2 Global Degenerative Disc Disease Threpeutics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Degenerative Disc Disease Threpeutics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Degenerative Disc Disease Threpeutics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Degenerative Disc Disease Threpeutics Competitor Landscape by Players
3.1 Degenerative Disc Disease Threpeutics Sales by Manufacturers
3.1.1 Degenerative Disc Disease Threpeutics Sales by Manufacturers (2015-2020)
3.1.2 Degenerative Disc Disease Threpeutics Sales Market Share by Manufacturers (2015-2020)
3.2 Degenerative Disc Disease Threpeutics Revenue by Manufacturers
3.2.1 Degenerative Disc Disease Threpeutics Revenue by Manufacturers (2015-2020)
3.2.2 Degenerative Disc Disease Threpeutics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Degenerative Disc Disease Threpeutics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Degenerative Disc Disease Threpeutics Revenue in 2019
3.2.5 Global Degenerative Disc Disease Threpeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Degenerative Disc Disease Threpeutics Price by Manufacturers
3.4 Degenerative Disc Disease Threpeutics Manufacturing Base Distribution, Product Types
3.4.1 Degenerative Disc Disease Threpeutics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Degenerative Disc Disease Threpeutics Product Type
3.4.3 Date of International Manufacturers Enter into Degenerative Disc Disease Threpeutics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Degenerative Disc Disease Threpeutics Market Size by Type (2015-2020)
4.1.1 Global Degenerative Disc Disease Threpeutics Sales by Type (2015-2020)
4.1.2 Global Degenerative Disc Disease Threpeutics Revenue by Type (2015-2020)
4.1.3 Degenerative Disc Disease Threpeutics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Degenerative Disc Disease Threpeutics Market Size Forecast by Type (2021-2026)
4.2.1 Global Degenerative Disc Disease Threpeutics Sales Forecast by Type (2021-2026)
4.2.2 Global Degenerative Disc Disease Threpeutics Revenue Forecast by Type (2021-2026)
4.2.3 Degenerative Disc Disease Threpeutics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Degenerative Disc Disease Threpeutics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Degenerative Disc Disease Threpeutics Market Size by Application (2015-2020)
5.1.1 Global Degenerative Disc Disease Threpeutics Sales by Application (2015-2020)
5.1.2 Global Degenerative Disc Disease Threpeutics Revenue by Application (2015-2020)
5.1.3 Degenerative Disc Disease Threpeutics Price by Application (2015-2020)
5.2 Degenerative Disc Disease Threpeutics Market Size Forecast by Application (2021-2026)
5.2.1 Global Degenerative Disc Disease Threpeutics Sales Forecast by Application (2021-2026)
5.2.2 Global Degenerative Disc Disease Threpeutics Revenue Forecast by Application (2021-2026)
5.2.3 Global Degenerative Disc Disease Threpeutics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Degenerative Disc Disease Threpeutics by Country
6.1.1 North America Degenerative Disc Disease Threpeutics Sales by Country
6.1.2 North America Degenerative Disc Disease Threpeutics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Degenerative Disc Disease Threpeutics Market Facts & Figures by Type
6.3 North America Degenerative Disc Disease Threpeutics Market Facts & Figures by Application
7 Europe
7.1 Europe Degenerative Disc Disease Threpeutics by Country
7.1.1 Europe Degenerative Disc Disease Threpeutics Sales by Country
7.1.2 Europe Degenerative Disc Disease Threpeutics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Degenerative Disc Disease Threpeutics Market Facts & Figures by Type
7.3 Europe Degenerative Disc Disease Threpeutics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Degenerative Disc Disease Threpeutics by Region
8.1.1 Asia Pacific Degenerative Disc Disease Threpeutics Sales by Region
8.1.2 Asia Pacific Degenerative Disc Disease Threpeutics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Degenerative Disc Disease Threpeutics Market Facts & Figures by Type
8.3 Asia Pacific Degenerative Disc Disease Threpeutics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Degenerative Disc Disease Threpeutics by Country
9.1.1 Latin America Degenerative Disc Disease Threpeutics Sales by Country
9.1.2 Latin America Degenerative Disc Disease Threpeutics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Degenerative Disc Disease Threpeutics Market Facts & Figures by Type
9.3 Central & South America Degenerative Disc Disease Threpeutics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Degenerative Disc Disease Threpeutics by Country
10.1.1 Middle East and Africa Degenerative Disc Disease Threpeutics Sales by Country
10.1.2 Middle East and Africa Degenerative Disc Disease Threpeutics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Degenerative Disc Disease Threpeutics Market Facts & Figures by Type
10.3 Middle East and Africa Degenerative Disc Disease Threpeutics Market Facts & Figures by Application
11 Company Profiles
11.1 AnGes MG Inc
11.1.1 AnGes MG Inc Corporation Information
11.1.2 AnGes MG Inc Description and Business Overview
11.1.3 AnGes MG Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AnGes MG Inc Degenerative Disc Disease Threpeutics Products Offered
11.1.5 AnGes MG Inc Related Developments
11.2 Biopharm GmbH
11.2.1 Biopharm GmbH Corporation Information
11.2.2 Biopharm GmbH Description and Business Overview
11.2.3 Biopharm GmbH Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biopharm GmbH Degenerative Disc Disease Threpeutics Products Offered
11.2.5 Biopharm GmbH Related Developments
11.3 BioRestorative Therapies Inc
11.3.1 BioRestorative Therapies Inc Corporation Information
11.3.2 BioRestorative Therapies Inc Description and Business Overview
11.3.3 BioRestorative Therapies Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 BioRestorative Therapies Inc Degenerative Disc Disease Threpeutics Products Offered
11.3.5 BioRestorative Therapies Inc Related Developments
11.4 Bone Therapeutics SA
11.4.1 Bone Therapeutics SA Corporation Information
11.4.2 Bone Therapeutics SA Description and Business Overview
11.4.3 Bone Therapeutics SA Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bone Therapeutics SA Degenerative Disc Disease Threpeutics Products Offered
11.4.5 Bone Therapeutics SA Related Developments
11.5 DiscGenics Inc
11.5.1 DiscGenics Inc Corporation Information
11.5.2 DiscGenics Inc Description and Business Overview
11.5.3 DiscGenics Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 DiscGenics Inc Degenerative Disc Disease Threpeutics Products Offered
11.5.5 DiscGenics Inc Related Developments
11.6 Osiris Therapeutics Inc
11.6.1 Osiris Therapeutics Inc Corporation Information
11.6.2 Osiris Therapeutics Inc Description and Business Overview
11.6.3 Osiris Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Osiris Therapeutics Inc Degenerative Disc Disease Threpeutics Products Offered
11.6.5 Osiris Therapeutics Inc Related Developments
11.7 Samumed LLC
11.7.1 Samumed LLC Corporation Information
11.7.2 Samumed LLC Description and Business Overview
11.7.3 Samumed LLC Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Samumed LLC Degenerative Disc Disease Threpeutics Products Offered
11.7.5 Samumed LLC Related Developments
11.8 TissueGene Inc
11.8.1 TissueGene Inc Corporation Information
11.8.2 TissueGene Inc Description and Business Overview
11.8.3 TissueGene Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 TissueGene Inc Degenerative Disc Disease Threpeutics Products Offered
11.8.5 TissueGene Inc Related Developments
11.9 U.S. Stem Cell Inc
11.9.1 U.S. Stem Cell Inc Corporation Information
11.9.2 U.S. Stem Cell Inc Description and Business Overview
11.9.3 U.S. Stem Cell Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 U.S. Stem Cell Inc Degenerative Disc Disease Threpeutics Products Offered
11.9.5 U.S. Stem Cell Inc Related Developments
11.10 Yuhan Corp
11.10.1 Yuhan Corp Corporation Information
11.10.2 Yuhan Corp Description and Business Overview
11.10.3 Yuhan Corp Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Yuhan Corp Degenerative Disc Disease Threpeutics Products Offered
11.10.5 Yuhan Corp Related Developments
11.1 AnGes MG Inc
11.1.1 AnGes MG Inc Corporation Information
11.1.2 AnGes MG Inc Description and Business Overview
11.1.3 AnGes MG Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AnGes MG Inc Degenerative Disc Disease Threpeutics Products Offered
11.1.5 AnGes MG Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Degenerative Disc Disease Threpeutics Market Estimates and Projections by Region
12.1.1 Global Degenerative Disc Disease Threpeutics Sales Forecast by Regions 2021-2026
12.1.2 Global Degenerative Disc Disease Threpeutics Revenue Forecast by Regions 2021-2026
12.2 North America Degenerative Disc Disease Threpeutics Market Size Forecast (2021-2026)
12.2.1 North America: Degenerative Disc Disease Threpeutics Sales Forecast (2021-2026)
12.2.2 North America: Degenerative Disc Disease Threpeutics Revenue Forecast (2021-2026)
12.2.3 North America: Degenerative Disc Disease Threpeutics Market Size Forecast by Country (2021-2026)
12.3 Europe Degenerative Disc Disease Threpeutics Market Size Forecast (2021-2026)
12.3.1 Europe: Degenerative Disc Disease Threpeutics Sales Forecast (2021-2026)
12.3.2 Europe: Degenerative Disc Disease Threpeutics Revenue Forecast (2021-2026)
12.3.3 Europe: Degenerative Disc Disease Threpeutics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Degenerative Disc Disease Threpeutics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Degenerative Disc Disease Threpeutics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Degenerative Disc Disease Threpeutics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Degenerative Disc Disease Threpeutics Market Size Forecast by Region (2021-2026)
12.5 Latin America Degenerative Disc Disease Threpeutics Market Size Forecast (2021-2026)
12.5.1 Latin America: Degenerative Disc Disease Threpeutics Sales Forecast (2021-2026)
12.5.2 Latin America: Degenerative Disc Disease Threpeutics Revenue Forecast (2021-2026)
12.5.3 Latin America: Degenerative Disc Disease Threpeutics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Degenerative Disc Disease Threpeutics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Degenerative Disc Disease Threpeutics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Degenerative Disc Disease Threpeutics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Degenerative Disc Disease Threpeutics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Degenerative Disc Disease Threpeutics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Degenerative Disc Disease Threpeutics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Degenerative Disc Disease Threpeutics Market Segments
Table 2. Ranking of Global Top Degenerative Disc Disease Threpeutics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ALLOB
Table 5. Major Manufacturers of AMG-0101
Table 6. Major Manufacturers of BRTX-100
Table 7. Major Manufacturers of OTICR-01
Table 8. Major Manufacturers of Others
Table 9. Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Degenerative Disc Disease Threpeutics Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Degenerative Disc Disease Threpeutics Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Degenerative Disc Disease Threpeutics Sales Market Share by Regions (2015-2020)
Table 13. Global Degenerative Disc Disease Threpeutics Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Degenerative Disc Disease Threpeutics Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Degenerative Disc Disease Threpeutics Sales Share by Manufacturers (2015-2020)
Table 16. Global Degenerative Disc Disease Threpeutics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Degenerative Disc Disease Threpeutics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Degenerative Disc Disease Threpeutics as of 2019)
Table 18. Degenerative Disc Disease Threpeutics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Degenerative Disc Disease Threpeutics Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Degenerative Disc Disease Threpeutics Price (2015-2020) (USD/Pcs)
Table 21. Degenerative Disc Disease Threpeutics Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Degenerative Disc Disease Threpeutics Product Type
Table 23. Date of International Manufacturers Enter into Degenerative Disc Disease Threpeutics Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Degenerative Disc Disease Threpeutics Sales by Type (2015-2020) (K Pcs)
Table 26. Global Degenerative Disc Disease Threpeutics Sales Share by Type (2015-2020)
Table 27. Global Degenerative Disc Disease Threpeutics Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Degenerative Disc Disease Threpeutics Revenue Share by Type (2015-2020)
Table 29. Degenerative Disc Disease Threpeutics Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Degenerative Disc Disease Threpeutics Sales by Application (2015-2020) (K Pcs)
Table 31. Global Degenerative Disc Disease Threpeutics Sales Share by Application (2015-2020)
Table 32. North America Degenerative Disc Disease Threpeutics Sales by Country (2015-2020) (K Pcs)
Table 33. North America Degenerative Disc Disease Threpeutics Sales Market Share by Country (2015-2020)
Table 34. North America Degenerative Disc Disease Threpeutics Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Degenerative Disc Disease Threpeutics Revenue Market Share by Country (2015-2020)
Table 36. North America Degenerative Disc Disease Threpeutics Sales by Type (2015-2020) (K Pcs)
Table 37. North America Degenerative Disc Disease Threpeutics Sales Market Share by Type (2015-2020)
Table 38. North America Degenerative Disc Disease Threpeutics Sales by Application (2015-2020) (K Pcs)
Table 39. North America Degenerative Disc Disease Threpeutics Sales Market Share by Application (2015-2020)
Table 40. Europe Degenerative Disc Disease Threpeutics Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Degenerative Disc Disease Threpeutics Sales Market Share by Country (2015-2020)
Table 42. Europe Degenerative Disc Disease Threpeutics Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Degenerative Disc Disease Threpeutics Revenue Market Share by Country (2015-2020)
Table 44. Europe Degenerative Disc Disease Threpeutics Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Degenerative Disc Disease Threpeutics Sales Market Share by Type (2015-2020)
Table 46. Europe Degenerative Disc Disease Threpeutics Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Degenerative Disc Disease Threpeutics Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Degenerative Disc Disease Threpeutics Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Degenerative Disc Disease Threpeutics Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Degenerative Disc Disease Threpeutics Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Degenerative Disc Disease Threpeutics Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Degenerative Disc Disease Threpeutics Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Degenerative Disc Disease Threpeutics Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Degenerative Disc Disease Threpeutics Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Degenerative Disc Disease Threpeutics Sales Market Share by Application (2015-2020)
Table 56. Latin America Degenerative Disc Disease Threpeutics Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Degenerative Disc Disease Threpeutics Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Degenerative Disc Disease Threpeutics Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Degenerative Disc Disease Threpeutics Revenue Market Share by Country (2015-2020)
Table 60. Latin America Degenerative Disc Disease Threpeutics Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Degenerative Disc Disease Threpeutics Sales Market Share by Type (2015-2020)
Table 62. Latin America Degenerative Disc Disease Threpeutics Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Degenerative Disc Disease Threpeutics Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Degenerative Disc Disease Threpeutics Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Degenerative Disc Disease Threpeutics Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Degenerative Disc Disease Threpeutics Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Degenerative Disc Disease Threpeutics Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Degenerative Disc Disease Threpeutics Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Degenerative Disc Disease Threpeutics Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Degenerative Disc Disease Threpeutics Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Degenerative Disc Disease Threpeutics Sales Market Share by Application (2015-2020)
Table 72. AnGes MG Inc Corporation Information
Table 73. AnGes MG Inc Description and Major Businesses
Table 74. AnGes MG Inc Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. AnGes MG Inc Product
Table 76. AnGes MG Inc Recent Development
Table 77. Biopharm GmbH Corporation Information
Table 78. Biopharm GmbH Description and Major Businesses
Table 79. Biopharm GmbH Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Biopharm GmbH Product
Table 81. Biopharm GmbH Recent Development
Table 82. BioRestorative Therapies Inc Corporation Information
Table 83. BioRestorative Therapies Inc Description and Major Businesses
Table 84. BioRestorative Therapies Inc Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. BioRestorative Therapies Inc Product
Table 86. BioRestorative Therapies Inc Recent Development
Table 87. Bone Therapeutics SA Corporation Information
Table 88. Bone Therapeutics SA Description and Major Businesses
Table 89. Bone Therapeutics SA Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Bone Therapeutics SA Product
Table 91. Bone Therapeutics SA Recent Development
Table 92. DiscGenics Inc Corporation Information
Table 93. DiscGenics Inc Description and Major Businesses
Table 94. DiscGenics Inc Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. DiscGenics Inc Product
Table 96. DiscGenics Inc Recent Development
Table 97. Osiris Therapeutics Inc Corporation Information
Table 98. Osiris Therapeutics Inc Description and Major Businesses
Table 99. Osiris Therapeutics Inc Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Osiris Therapeutics Inc Product
Table 101. Osiris Therapeutics Inc Recent Development
Table 102. Samumed LLC Corporation Information
Table 103. Samumed LLC Description and Major Businesses
Table 104. Samumed LLC Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Samumed LLC Product
Table 106. Samumed LLC Recent Development
Table 107. TissueGene Inc Corporation Information
Table 108. TissueGene Inc Description and Major Businesses
Table 109. TissueGene Inc Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. TissueGene Inc Product
Table 111. TissueGene Inc Recent Development
Table 112. U.S. Stem Cell Inc Corporation Information
Table 113. U.S. Stem Cell Inc Description and Major Businesses
Table 114. U.S. Stem Cell Inc Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. U.S. Stem Cell Inc Product
Table 116. U.S. Stem Cell Inc Recent Development
Table 117. Yuhan Corp Corporation Information
Table 118. Yuhan Corp Description and Major Businesses
Table 119. Yuhan Corp Degenerative Disc Disease Threpeutics Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Yuhan Corp Product
Table 121. Yuhan Corp Recent Development
Table 122. Global Degenerative Disc Disease Threpeutics Sales Forecast by Regions (2021-2026) (K Pcs)
Table 123. Global Degenerative Disc Disease Threpeutics Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Degenerative Disc Disease Threpeutics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Degenerative Disc Disease Threpeutics Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Degenerative Disc Disease Threpeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. North America: Degenerative Disc Disease Threpeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Degenerative Disc Disease Threpeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Europe: Degenerative Disc Disease Threpeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Degenerative Disc Disease Threpeutics Sales Forecast by Region (2021-2026) (K Pcs)
Table 131. Asia Pacific: Degenerative Disc Disease Threpeutics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Degenerative Disc Disease Threpeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 133. Latin America: Degenerative Disc Disease Threpeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Degenerative Disc Disease Threpeutics Sales Forecast by Country (2021-2026) (K Pcs)
Table 135. Middle East and Africa: Degenerative Disc Disease Threpeutics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Degenerative Disc Disease Threpeutics Players
Table 140. Degenerative Disc Disease Threpeutics Customers List
Table 141. Degenerative Disc Disease Threpeutics Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Degenerative Disc Disease Threpeutics Product Picture
Figure 2. Global Degenerative Disc Disease Threpeutics Sales Market Share by Type in 2020 & 2026
Figure 3. ALLOB Product Picture
Figure 4. AMG-0101 Product Picture
Figure 5. BRTX-100 Product Picture
Figure 6. OTICR-01 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Degenerative Disc Disease Threpeutics Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Homecare
Figure 12. Degenerative Disc Disease Threpeutics Report Years Considered
Figure 13. Global Degenerative Disc Disease Threpeutics Market Size 2015-2026 (US$ Million)
Figure 14. Global Degenerative Disc Disease Threpeutics Sales 2015-2026 (K Pcs)
Figure 15. Global Degenerative Disc Disease Threpeutics Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Degenerative Disc Disease Threpeutics Sales Market Share by Region (2015-2020)
Figure 17. Global Degenerative Disc Disease Threpeutics Sales Market Share by Region in 2019
Figure 18. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Region (2015-2020)
Figure 19. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Region in 2019
Figure 20. Global Degenerative Disc Disease Threpeutics Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Degenerative Disc Disease Threpeutics Revenue in 2019
Figure 22. Degenerative Disc Disease Threpeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Degenerative Disc Disease Threpeutics Sales Market Share by Type (2015-2020)
Figure 24. Global Degenerative Disc Disease Threpeutics Sales Market Share by Type in 2019
Figure 25. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2015-2020)
Figure 26. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type in 2019
Figure 27. Global Degenerative Disc Disease Threpeutics Market Share by Price Range (2015-2020)
Figure 28. Global Degenerative Disc Disease Threpeutics Sales Market Share by Application (2015-2020)
Figure 29. Global Degenerative Disc Disease Threpeutics Sales Market Share by Application in 2019
Figure 30. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Application (2015-2020)
Figure 31. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Application in 2019
Figure 32. North America Degenerative Disc Disease Threpeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Degenerative Disc Disease Threpeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Degenerative Disc Disease Threpeutics Sales Market Share by Country in 2019
Figure 35. North America Degenerative Disc Disease Threpeutics Revenue Market Share by Country in 2019
Figure 36. U.S. Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Degenerative Disc Disease Threpeutics Market Share by Type in 2019
Figure 41. North America Degenerative Disc Disease Threpeutics Market Share by Application in 2019
Figure 42. Europe Degenerative Disc Disease Threpeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Degenerative Disc Disease Threpeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Degenerative Disc Disease Threpeutics Sales Market Share by Country in 2019
Figure 45. Europe Degenerative Disc Disease Threpeutics Revenue Market Share by Country in 2019
Figure 46. Germany Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Degenerative Disc Disease Threpeutics Market Share by Type in 2019
Figure 57. Europe Degenerative Disc Disease Threpeutics Market Share by Application in 2019
Figure 58. Asia Pacific Degenerative Disc Disease Threpeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Degenerative Disc Disease Threpeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Degenerative Disc Disease Threpeutics Sales Market Share by Region in 2019
Figure 61. Asia Pacific Degenerative Disc Disease Threpeutics Revenue Market Share by Region in 2019
Figure 62. China Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Degenerative Disc Disease Threpeutics Market Share by Type in 2019
Figure 85. Asia Pacific Degenerative Disc Disease Threpeutics Market Share by Application in 2019
Figure 86. Latin America Degenerative Disc Disease Threpeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Degenerative Disc Disease Threpeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Degenerative Disc Disease Threpeutics Sales Market Share by Country in 2019
Figure 89. Latin America Degenerative Disc Disease Threpeutics Revenue Market Share by Country in 2019
Figure 90. Mexico Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Degenerative Disc Disease Threpeutics Market Share by Type in 2019
Figure 97. Latin America Degenerative Disc Disease Threpeutics Market Share by Application in 2019
Figure 98. Middle East and Africa Degenerative Disc Disease Threpeutics Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Degenerative Disc Disease Threpeutics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Degenerative Disc Disease Threpeutics Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Degenerative Disc Disease Threpeutics Revenue Market Share by Country in 2019
Figure 102. Turkey Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Degenerative Disc Disease Threpeutics Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Degenerative Disc Disease Threpeutics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Degenerative Disc Disease Threpeutics Market Share by Type in 2019
Figure 109. Middle East and Africa Degenerative Disc Disease Threpeutics Market Share by Application in 2019
Figure 110. North America Degenerative Disc Disease Threpeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Degenerative Disc Disease Threpeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Degenerative Disc Disease Threpeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Degenerative Disc Disease Threpeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Degenerative Disc Disease Threpeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Degenerative Disc Disease Threpeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Degenerative Disc Disease Threpeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Degenerative Disc Disease Threpeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Degenerative Disc Disease Threpeutics Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Degenerative Disc Disease Threpeutics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
スリップディスクの世界市場（～2026年） Slipped (Herniated) disc occurs when a soft cushion of tissue between the bones in spine pushes out and is painful when it presses on nerves. The most common symptoms of slipped disc are loss of motor control, pain etc. Slipped disc mainly occurs due to weaker outer ring that allows inner portion to…- 脊椎非融合技術の世界市場（～2026年） Non fusion spinal technologies are used for the patients who are suffering from the problem of gradual disc damage, degenerative disc disease often results in disc herniation and chronic back or neck pain. Global spinal non fusion technologies market is anticipated to exhibit a significant market gr…
- 液体用フィルターディスクの世界市場（～2026年） A disc filter is a type of water filter used primarily in irrigation, similar to a screen filter, except that the filter cartridge is made of a number of plastic discs stacked on top of each other like a pile of poker chips. Each disc is covered with small grooves or bumps. Market Analysis and Insig…
- セラミックアルミナフラップディスクの世界市場（～2026年） Market Analysis and Insights: Global Ceramic Alumina Flap Disc Market The global Ceramic Alumina Flap Disc market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ceramic Alumina Flap Disc Scope and Market Size Ceramic Alumina…
- クラッベ病治療の世界市場（～2026年） Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessi…